ODDB.org: Open Drug Database

Mepha Pharma AG - Rivaroxaban-Mepha 15 mg, Hartkapseln

Swissmedic Registration	69305	Sequence	02
Product name	Rivaroxaban-Mepha 15 mg	Description	Hartkapseln
ATC-Classification	B01AF01	ATC-Description	Rivaroxaban
Introduction of Sequence	31.01.2025

Composition

rivaroxabanum 15.0 mg, cellulosum microcristallinum, lactosum monohydricum 19.50 mg, tricalcii dicitras tetrahydricus, povidonum K 25, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 172 (flavum), E 171, carrageenanum, kalii chloridum, aqua purificata, hypromellosum, pro capsula corresp. natrium 0.38 mg et kalium 0.14 mg.

Packungsbestandteile

Galenic Form

Capsules

Excipiens

Active Agent	Dose
	15 mg

Inactive agents	Dose	additional_information

Aqua Purificata



		color.
		Kapselhülle
Hypromellosum
Potassium Chloride
Lactose Monohydrate	19.5 mg


	25
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	Out of trade (MedRef)
004	10	PR	PR	B	Yes
005	14	PR	PR	B	Yes
006	28	PR	PR	B	Yes
007	42	PR	PR	B	Yes
008	98	PR	PR	B	Yes

2025	©ywesee GmbH